{"@type":"Dataset","integmet_study":"MTBLS2015","mesh_chemical_id":["https://identifiers.org/mesh:D002784","https://identifiers.org/mesh:D005227","https://identifiers.org/mesh:D008055"],"mesh_chemical_pubtator_kw":["cholesterol","fatty acid","lipid"],"mesh_disease_id":["https://identifiers.org/mesh:D018805","https://identifiers.org/mesh:D012772"],"mesh_disease_pubtator_kw":["sepsis","septic shock"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:1314","https://identifiers.org/taxonomy:9606","https://identifiers.org/taxonomy:1280","https://identifiers.org/taxonomy:562"],"ncbi_taxonomy_pubtator_kw":["Streptococcus pyogenes","human","Staphylococcus aureus","Escherichia coli"],"source_id":"https://identifiers.org/metabolights:MTBLS2015","study_findings":null,"study_observation":"Escherichia coli assays using GC-MS and LC-MS","study_summary":"Escherichia coli assays for antibiotic resistance.","study_title_original":"Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)"}